Skip to menu Skip to content Skip to footer

2025

Journal Article

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

Pirmani, Ashkan, De Brouwer, Edward, Arany, Ádám, Oldenhof, Martijn, Passemiers, Antoine, Faes, Axel, Kalincik, Tomas, Ozakbas, Serkan, Gouider, Riadh, Willekens, Barbara, Horakova, Dana, Havrdova, Eva Kubala, Patti, Francesco, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Grammond, Pierre, Cartechini, Elisabetta, Roos, Izanne, Boz, Cavit, Alroughani, Raed, Amato, Maria Pia, Buzzard, Katherine, Lechner-Scott, Jeannette, Guimarães, Joana, Solaro, Claudio, Gerlach, Oliver, Soysal, Aysun, Kuhle, Jens ... Moreau, Yves (2025). Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data. npj Digital Medicine, 8 (1) 478, 1. doi: 10.1038/s41746-025-01788-8

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

2025

Journal Article

Co-Design and Non-Randomised Pilot Evaluation of Resources Developed to Optimise Saliva Management in People with Motor Neurone Disease

Taubert, Shana, Collins, Annette, Henderson, Robert, McCombe, Pamela, Tang, Lily, Kramer, Katrina, Wishart, Laurelie and Burns, Clare (2025). Co-Design and Non-Randomised Pilot Evaluation of Resources Developed to Optimise Saliva Management in People with Motor Neurone Disease. Healthcare, 13 (21) 2813, 2813. doi: 10.3390/healthcare13212813

Co-Design and Non-Randomised Pilot Evaluation of Resources Developed to Optimise Saliva Management in People with Motor Neurone Disease

2025

Journal Article

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva Kubala, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas,, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia Joseph, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin, Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Girard, Marc ... Study Group, MSBase (2025). Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, 97 (1) jnnp-2025-336513, jnnp-2025. doi: 10.1136/jnnp-2025-336513

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

2025

Journal Article

Epigenetic profiles of tissue informative CpGs inform ALS disease status and progression

Caggiano, Christa, Morselli, Marco, Qian, Xiaoyu, Celona, Barbara, Thompson, Michael J., Wani, Shivangi, Tosevska, Anela, Taraszka, Kodi, Heuer, Galen, Ngo, Shyuan T., Steyn, Frederick J., Nestor, Peter J., Wallace, Leanne, Mccombe, Pamela, Heggie, Susan, Thorpe, Kathryn, Mcelligott, Caitlin, English, Gemyka, Henders, Anjali, Henderson, Robert, Lomen-Hoerth, Catherine, Wray, Naomi R., Mcrae, Allan F., Pellegrini, Matteo, Garton, Fleur C. and Zaitlen, Noah (2025). Epigenetic profiles of tissue informative CpGs inform ALS disease status and progression. Genome Medicine, 17 (1) 115, 115. doi: 10.1186/s13073-025-01542-5

Epigenetic profiles of tissue informative CpGs inform ALS disease status and progression

2025

Conference Publication

YI5 Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies

Yeow, Dennis, Stevanovski, Igor, Reis, Andre LM, Rudaks, Laura I, Chintalaphani, Sanjog R, Grosz, Bianca, Liang, Christina, Morris, Katrina A, Reddel, Stephen, McCombe, Pamela A, Zhu, Danqing, Stoll, Marion, Davis, Ryan L, Manser, David, Tchan, Michel, Worgan, Lisa, Hannaford, Andrew, Sue, Carolyn M, Shandiz, Ehsan, Ahmad, Kate E, Ghaoui, Roula, Barnes, Stephanie L, Sturm, Jonathan, Willard, Anna, Hawke, Simon, Ng, Karl, Cheong, Pak Leng, Kennerson, Marina L, Kumar, Kishore R and Deveson, Ira W (2025). YI5 Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies. BMJ Publishing Group Ltd. doi: 10.1136/bmjno-2025-anzan.5

YI5 Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies

2025

Conference Publication

Preserving neurological function in people at high and low risk of aggressive multiple sclerosis

Roos, Izanne, Sharmin, Sifat, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Walt, Anneke van der, Butzkueven, Helmut, Barnett, Michael, Macdonell, Richard, John, Nevin, Hodgkinson, Suzanne, Slee, Mark, McCombe, Pamela, Garber, Justin, Kermode, Allan G., Fabis-Pedrini, Marzena J., Carroll, William M., Taylor, Bruce, Vukusic, Sandra and Kalincik, Tomas (2025). Preserving neurological function in people at high and low risk of aggressive multiple sclerosis. ANZAN Annual Scientific Meeting 2025, Sydney, NSW Australia, 23-26 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.153

Preserving neurological function in people at high and low risk of aggressive multiple sclerosis

2025

Conference Publication

YI6 MS outcomes in breast cancer survivors and the influence of chemotherapy

Nesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Lechner-Scott, Jeannette, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Pedrini, Marzena, Carroll, William, Barnett, Michael, Taylor, Bruce, Hodgkinson, Suzanne, Barnett, Michael, Mccombe, Pamela, Reddel, Stephen, Vucic, Steve, Ramanathan, Sudarshini, Macdonell, Richard ... Jokubaitis, Vilija (2025). YI6 MS outcomes in breast cancer survivors and the influence of chemotherapy. BMJ Publishing Group Ltd. doi: 10.1136/bmjno-2025-anzan.6

YI6 MS outcomes in breast cancer survivors and the influence of chemotherapy

2025

Journal Article

Menopause Impact on Multiple Sclerosis Disability Progression

Bridge, Francesca, Sanfilippo, Paul G., Zhu, Chao, Skibina, Olga, Nguyen, Ai-Lan, Kalincik, Tomas, Buzzard, Katherine, Taylor, Bruce V., MacIntyre, Jennifer, Hall, Lesley-Ann, Slee, Mark, Macdonell, Richard, Maltby, Vicki, Lechner-Scott, Jeannette, McCombe, Pamela, Butzkueven, Helmut, van der Walt, Anneke and Jokubaitis, Vilija G. (2025). Menopause Impact on Multiple Sclerosis Disability Progression. JAMA Neurology, 82 (12), 1219-1226. doi: 10.1001/jamaneurol.2025.3538

Menopause Impact on Multiple Sclerosis Disability Progression

2025

Journal Article

Living with dysphagia and dysarthria: a qualitative exploration of the perspectives of people with motor neuron disease and their caregivers

Packer, Rebecca, Rumbach, Anna, Farrell, Anna, Hutchinson, Nicole, Verner-Wren, Stacey, Henderson, Robert and McCombe, Pamela (2025). Living with dysphagia and dysarthria: a qualitative exploration of the perspectives of people with motor neuron disease and their caregivers. Healthcare, 13 (18) 2306, 1. doi: 10.3390/healthcare13182306

Living with dysphagia and dysarthria: a qualitative exploration of the perspectives of people with motor neuron disease and their caregivers

2025

Conference Publication

Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update

Spelman, Tim, van der Walt, Anneke, Ozakbas, Serkan, Horakova, Dana, Alroughani, Raed, Kalincik, Tomas, Boz, Cavit, Buzzard, Katherine, Kermode, Allan, Gerlach, O., Foschi, Matteo, Jakob, Gregor Brecl, Grigoriadis, Nikolaos, Prevost, Julie, Duquette, Pierre, Lapointe, Emmanuelle, D'Amico, Emanuele, Ampapa, Radek, Gross-Paju, Katrin, Grammond, Pierre, Cardenas-Robledo, Simon, Houskova, Jana, Khoury, Samia, Maimone, Davide, Sanchez, Jose Luis, McCombe, Pamela, Slee, Mark, Taylor, Bruce, Blanco, Yolanda ... Butzkueven, Helmut (2025). Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update

2025

Conference Publication

Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation

Daruwalla, Cyrus, Kremler, Courtney, Patti, Francesco, Libertinova, Jana, Ozakbas, Serkan, Peterka, Marek, Vachova, Marta, Boz, Cavit, Scott, Jeannette Lechner, Roos, Izanne, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Khoury, Samia, van der Walt, Anneke, Butzkueven, Helmut, Meca-Lallana, Jose E., Rous, Zuzana, Habek, Mario, Alroughani, Raed, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Buzzard, Katherine, Skibina, Olga, Gray, Orla, Mccombe, Pamela, Izquierdo Ayuso, Guillermo, Eichau, Sara ... Brown, William (2025). Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation

2025

Journal Article

Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease

Shaw, Thomas B., Ribeiro, Fernanda L., Zhu, Xiangyun, Aiken, Patrick, Bollmann, Saskia, Bollmann, Steffen, Chang, Jeryn, Chidley, Kali, Dempsey-Jones, Harriet, Eftekhari, Zeinab, Gillespie, Jennifer, Henderson, Robert D., Kiernan, Matthew C., Ktena, Ira, McCombe, Pamela A., Ngo, Shyuan T., Taubert, Shana T., Whelan, Brooke-Mai, Ye, Xincheng, Steyn, Frederik J., Tu, Sicong and Barth, Markus (2025). Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease. Computers in Biology and Medicine, 196 (Part B) 110824, 1-13. doi: 10.1016/j.compbiomed.2025.110824

Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease

2025

Conference Publication

Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis

Stastna, Dominika, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Kovarova, Ivana, Barnett, Michael, Kalincik, Tomas, Buzzard, Katherine, van der Walt, Anneke, Macdonell, Richard, Scott, Jeannette Lechner, John, Nevin A., Mccombe, Pamela, Hodgkinson, Suzanne, Taylor, Bruce, Slee, Mark, Garber, Justin, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Hradilek, Pavel, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana ... Fistravec, Gregor (2025). Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis

2025

Conference Publication

Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase

D'Amico, Emanuele, Zanghi, Aurora, Spelman, Tim, Kermode, Allan G., Pedrini, Marzena, Carroll, William, Lechner-Scott, Jeannette, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Kalincik, Tomas, Roos, Izanne, Boz, Cavit, Ozakbas, Serkan, Barnett, Michael, Hodgkinson, Suzanne, Habek, Mario, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Alroughani, Raed, Laureys, Guy, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo H., Eichau, Sara, Mccombe, Pamela, Massey, Jennifer, Aragon de Vecino, Maria Cecilia ... Gerlach, Oliver (2025). Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase

2025

Conference Publication

Real-World Management of Multiple Sclerosis after Cancer Chemotherapy

Nesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Scott, Jeannette Lechner, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Carroll, William, Barnett, Michael, Hodgkinson, Suzanne, Grand'Maison, Francois, Horakova, Dana, Havrdova, Eva, Blanco, Yolanda, Hradilek, Pavel, Vachova, Marta, Habek, Mario, Maimone, Davide ... Jokubaitis, Vilija (2025). Real-World Management of Multiple Sclerosis after Cancer Chemotherapy. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-World Management of Multiple Sclerosis after Cancer Chemotherapy

2025

Conference Publication

Treatment strategies after cell-trafficking agents in MS patients older than 50 years

Muller, Jannis, Benkert, Pascal, Horakova, Dana, Havrdova, Eva, Buzzard, Katherine, Skibina, Olga, Ozakbas, Serkan, Lechner Scott, Jeannette, Izquierdo Ayuso, Guillermo, Eichau, Sara, Weinstock-Guttman, Bianca, Hodgkinson, Suzanne, Grammond, Pierre, Barnett, Michael, Prat, Alexandre, Girard, Marc, Duquette, Pierre, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Meca-Lallana, Jose E., Prevost, Julie, Gerlach, O., Boz, Cavit, McCombe, Pamela, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan, Pedrini, Marzena ... Roos, Izanne (2025). Treatment strategies after cell-trafficking agents in MS patients older than 50 years. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Treatment strategies after cell-trafficking agents in MS patients older than 50 years

2025

Conference Publication

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Scott, Jeannette Lechner, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin A., Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Terzi, Murat ... van der Walt, Anneke (2025). Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

2025

Conference Publication

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

Iqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Shaygannejad, Vahid, Karabudak, Rana, Patti, Francesco, Zamzam, Dina, Alroughani, Raed, Etemadifar, Masoud, Boz, Cavit, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Amato, Maria Pia, Grand'Maison, Francois, Kermode, Allan, Pedrini, Marzena, Carroll, William, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin ... Kalincik, Tomas (2025). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

2025

Conference Publication

Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis

Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Oivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, J. William L., Coles, Alasdair, van der Walt, Anneke, Butzkueven, Helmut, Scott, Jeannette Lechner, Van Wijmeersch, Bart, Barnett, Michael, Laureys, Guy, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga, Di Gregorio, Maria ... Snowden, John (2025). Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis

2025

Conference Publication

Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis

Butzkueven, Helmut, van der Walt, Anneke, Spelman, Tim, Kermode, Allan, Pedrini, Marzena, Carroll, William, Scott, Jeannette Lechner, John, Nevin A., Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark, Buzzard, Katherine, Nelson, Morag, Schmitt, Birte and Martel, Kate (2025). Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis